Erlocip 150 mg Tablet
107,68$
68,56$
Erlocip 150 mg Tablet is a targeted therapy medication that plays a crucial role in managing specific cancer types, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. This innovative treatment works by inhibiting the action of epidermal growth factor receptor (EGFR) tyrosine kinases, which are involved in the proliferation of cancer cells. By blocking these signals, Erlocip helps to slow down or halt tumor growth, providing patients with a vital option in their cancer treatment regimen. However, it is essential to be aware of potential side effects, which may include skin rashes, diarrhea, and liver function abnormalities, necessitating regular monitoring. Patients should also discuss their medical history and any concurrent medications with their healthcare provider to avoid interactions and ensure safe usage. As with any cancer treatment, adherence to prescribed dosages and consultation with healthcare professionals can significantly enhance therapeutic outcomes. Erlocip 150 mg Tablet is not just a medication; it represents hope for those battling aggressive cancers, empowering patients in their fight against the disease.
Quantité
Active Pharmaceutical Ingredient
Uses
• Erlocip 150 mg tablet is primarily utilized for the treatment of non-small cell lung cancer, a prevalent form of lung cancer characterized by the rapid growth of malignant cells. This medication works by targeting specific proteins that promote cancer cell growth, thereby inhibiting tumor progression. Patients often present with symptoms such as a persistent cough, chest pain, and shortness of breath. By incorporating Erlocip 150 mg tablet into their treatment regimen, individuals may experience improved management of these symptoms.
• In the context of pancreatic cancer, Erlocip 150 mg tablet is often prescribed in conjunction with gemcitabine to enhance therapeutic outcomes. This combination approach aims to improve survival rates and control disease progression in patients diagnosed with this aggressive cancer. Typical symptoms of pancreatic cancer, such as abdominal pain and jaundice, can significantly impact quality of life. The use of Erlocip 150 mg tablet helps target cancerous cells, potentially alleviating some of these distressing symptoms.
• Erlocip 150 mg tablet is also indicated for patients who have previously undergone other cancer treatments and require a subsequent line of therapy. This medication can provide a valuable option for those whose cancers have not responded to initial therapies. By utilizing Erlocip 150 mg tablet, healthcare providers can tailor treatment plans to better suit individual patient needs. This approach often results in improved management of cancer-related symptoms and overall patient well-being.
• For individuals with advanced stages of non-small cell lung cancer or pancreatic cancer, Erlocip 150 mg tablet plays a critical role in palliative care. It is used to help manage symptoms and improve the quality of life for patients facing severe challenges due to their illness. By effectively targeting cancer growth, Erlocip 150 mg tablet can contribute to the relief of symptoms like fatigue and weight loss. This allows patients to maintain a better quality of life during their treatment journey.
Benefits
Erlocip Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Anti-cancer Drug Erlocip can help to slow the progression of cancer. Erlocip 150 mg Strip may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Erlocip 150 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
Like all medications, Erlocip 150 mg Strip can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Diarrhea
• Vomiting
• Gas
• Heartburn
• Mouth sores
• Constipation
• Headache
• Weight Loss
• Muscle or bone pain
• Anxiety
• Depression
• Hair loss
• Swelling of hands, feet, arms, lower legs or ankles
• Changes in nail and hair appearance
Common Side Effects
• Sudden chest pain
• Severe stomach pain
• Vision problems
• Heart attack
• Stroke
• Kidney or liver problems
• Rash
• Cough
• Peeling, blistering, cracked or dry skin
• Itching
• Tenderness
• Burning of the skin
• Fever
• Ingrown eyelash
• Pain in the neck, upper back or arms
• Difficult or slow speech
• Dizziness
• Weakness
• Dry mouth
• Dark urine
• Yellow or pale skin
How To Use
Take this medicine on an empty stomach, one hour before food or two hours after food. It is best to take exactly as prescribed by your doctor. Do not take more or less than directed. If you have trouble swallowing the Erlocip 150 mg, you may crush the tablets and mix the powder with a small amount of water. Drink the mixture immediately. You should take the Erlocip 150 mg Tablet at the same time each day to help you remember to take it. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not stop taking the Erlotinib Tablet 150 mg without first consulting your doctor.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Erlocip 150 mg Strip. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Erlocip 150 mg Strip is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Erlocip 150 mg Tablet is recommended. The use of Erlocip 150 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Erlocip Tablet. Erlocip 150 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Erlocip 150 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Erlocip Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Erlocip 150 mg Tablet is recommended. The use of Erlotinib Tablet 150 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Erlotinib Tablet 150 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erlocip 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Anti-cancer Drug Erlocip is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Erlocip 150 mg Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved